Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    23307281 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Comparison of GSK Biologicals' Meningococcal Vaccine (GSK134612) and Licensed MenC-CRM197 Vaccine in Healthy Children
Condition: Infections, Meningococcal
Interventions: Biological: GSK Biologicals' meningococcal vaccine GSK134612;   Biological: Menjugate

Indicates status has not been verified in more than two years